Kelsey S M, Lowdell M W, Newland A C
Department of Haematology, London Hospital, England.
Clin Exp Immunol. 1990 Jun;80(3):409-12. doi: 10.1111/j.1365-2249.1990.tb03302.x.
Defects of humoral immunity are well documented after bone marrow transplantation (BMT). Immunoglobulin recovery can be impaired and selective deficiencies of IgG subclasses have been reported. The nature of these deficiencies may reflect patterns of infection in the post-BMT period. We studied immunoglobulin and IgG subclass recovery in 20 long term (greater than 100 days) survivors of T depleted allogeneic BMT. Although there was no fall in mean levels of IgG, IgM or IgA for the patient group, 14 patients (70%) developed a deficiency of one or more immunoglobulin isotype at some stage post-BMT. Eight patients (40%) had deficiency of IgG, IgA and IgM and six had selective deficiencies. When IgG subclasses were measured it was seen that mean levels of IgG2 and IgG4 fell post-BMT with trough levels occurring at around 120 days post-transplant. Sixty per cent of patients developed IgG2 subclass deficiency and of these patients 78% had an associated IgG4 deficiency. Deficiencies of IgG1 and IgG3 were less common and less prolonged than those of IgG2 and IgG4; in addition, mean levels of IgG1 and IgG3 showed a rise early post-BMT. In conclusion, a majority of our patients developed immunoparesis following BMT, usually at around 120 days after transplantation. IgG2 subclass deficiency, often in association with IgG4 deficiency, is common and may occur despite normal total IgG levels. Deficiencies of immunoglobulin and IgG subclasses may persist for longer than 1 year post-BMT. Differing profiles of immunoglobulin and IgG subclass recovery may help dictate patterns of infection in long-term survivors of BMT.
骨髓移植(BMT)后体液免疫缺陷已有充分记录。免疫球蛋白的恢复可能受损,并且已有关于IgG亚类选择性缺乏的报道。这些缺陷的性质可能反映了BMT后时期的感染模式。我们研究了20例去除T细胞的异基因BMT长期(超过100天)存活者的免疫球蛋白和IgG亚类恢复情况。尽管患者组IgG、IgM或IgA的平均水平没有下降,但14例患者(70%)在BMT后的某个阶段出现了一种或多种免疫球蛋白同种型缺乏。8例患者(40%)存在IgG、IgA和IgM缺乏,6例有选择性缺乏。当检测IgG亚类时,发现BMT后IgG2和IgG4的平均水平下降,低谷水平出现在移植后约120天。60%的患者出现IgG2亚类缺乏,其中78%的患者伴有IgG4缺乏。IgG1和IgG3缺乏比IgG2和IgG4缺乏更少见且持续时间更短;此外,IgG1和IgG3的平均水平在BMT后早期呈上升趋势。总之,我们的大多数患者在BMT后出现免疫球蛋白减少,通常在移植后约120天。IgG2亚类缺乏,常与IgG4缺乏相关,很常见,并且即使总IgG水平正常也可能发生。免疫球蛋白和IgG亚类缺乏可能在BMT后持续超过1年。免疫球蛋白和IgG亚类恢复的不同情况可能有助于确定BMT长期存活者的感染模式。